Tansakul P et al, Dammarenediol-II synthase, the first dedicated enzyme for ginsenoside biosynthesis, in Panax ginseng, in FEBS Lett, vol. 580, n. 22, 2006, pp. 5143-5149, PMID16962103.
Popovich DG et al, Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line, in Archives of Biochemistry and Biophysics, vol. 406, n. 1, 2002, pp. 1-8, PMID12234484.
Hasegawa H et al, Main ginseng saponin metabolites formed by intestinal bacteria, in Planta medica, vol. 62, n. 5, 1996, pp. 453-457, PMID8923812.
Tawab MA et al, Degradation of ginsenosides in humans after oral adminstration, in Drug metabolism and disposition, vol. 31, n. 8, 2003, pp. 1065-1071, PMID12867496.
Oh SH et al, A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage, in Toxicology and Applied Pharmacology, vol. 194, n. 3, 2004, pp. 221-229, PMID14761678.
Hasegawa H et al, Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes, in Planta Medica, vol. 60, n. 2, 1994, pp. 153-157, PMID8202566.
Vuksan V et al, American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus, in Arch Intern Med, vol. 160, n. 7, 2000, pp. 1009-1013, PMID10761967.
Chang YS et al, Panax ginseng: A role in cancer therapy ?, in Integrative cancer therapies, vol. 2, n. 1, 2003, pp. 13-33, PMID12941165.
Zhan Y et al, Protective effects of ginsenoside on myocardiac ischemic and reperfusion injuries, in Chinese Medical Journal, vol. 74, n. 10, 1994, pp. 626-628, PMID7842343.
Pieralisi G et al, Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance during exercise., in Clinical Therapeutics, vol. 13, n. 3, 1991, pp. 373-382, PMID1954639.
Gross, D et al, Ginseng improves pulmonary functions and exercise capacity in patients with COPD, in Monaldi Archives for Chest Disease, vol. 57, n. 5-6, 2002, pp. 242-246, PMID12814035.
D'Angelo L et al, A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers, in Journal of Ethnopharmacology, vol. 16, n. 1, 1986, pp. 15-22, PMID3528672.
Choo MK et al, Antiallergic activity of ginseng and its ginsenosides, in Planta medica, vol. 69, n. 6, 2003, pp. 518-522, PMID12865969.
Hasegawa H et al, Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities., in Planta Medica, vol. 60, n. 3, 1994, pp. 240-243, PMID8073091.
Chisato Wakabayashi et al, In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration, in Oncology Research, vol. 9, 1997, pp. 411-417, PMID9436194.
Lee SJ et al, Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin, in Cancer Letters, vol. 144, n. 1, 1999, pp. 39-43, PMID10503876.
Lee BH et al, In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria, in Planta Medica, vol. 64, 1998, pp. 500-503, PMID9741293.
Yun TK et al, Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng?, in J Korean Med Sci, vol. 16, Suppl, 2001, pp. S19–S27, PMID11748373.
Tohda C et al, Amyloid beta (25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, a metabolite of protopanaxadiol-type saponins, in Neuropsychopharmacology, vol. 29, n. 5, 2004, pp. 860-868, PMID15010693.
Shu Zhu et al, Comparative study on triterpene saponins of ginseng drugs, in Planta medica, vol. 70, n. 7, 2004, pp. 666-677, PMID15303259.
